Could the Cochlear Limited (ASX:COH) share price be a long term market beater?
The post Is the Cochlear (ASX:COH) share price a long term market beater? appeared first on Motley Fool Australia. –
According to the United Nations, the global population aged 60 years stood at approximately 962 million in 2017.
This was more than twice as large as in 1980 when there were 382 million older persons worldwide.
The intergovernmental organisation is now expecting this figure to more than double again by 2050. At this point, it is projecting that the global population aged 60 years will reach almost 2.1 billion.
This population shift is widely expected to lead to increased demand for healthcare services over the next three decades. Which could be great news for Australian healthcare shares.
One that has been tipped as a big winner from this tailwind is Cochlear Limited (ASX: COH).
Cochlear is a leading global hearing solutions company. It manufactures some of the highest quality and most popular cochlear implant hearing devices in the world.
While 2020 has been a difficult year because of the pandemic’s impact on elective surgeries, a recent update appears to demonstrate that the worst is now over for the company. Furthermore, with potentially effective COVID-19 vaccines not far away, 2021 looks set to be a significantly better year for Cochlear.
Looking further ahead, the expected increase in the over-60 population over the coming decades will be good news for Cochlear. This is because as people age, their hearing will invariably fade and require some form of assistance.
One broker that is positive on the company is Macquarie. It recently put an outperform rating and $241.00 price target on the company’s shares. Its research appears to show that Cochlear has been winning market share.
In addition to this, its survey of US audiologists shows that its products are the most highly rated in the industry. The broker feels this bodes well as activity levels recover from the COVID disruption.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- What can you do when the ASX is down?
- Top brokers name 3 ASX shares to buy today
- Reasons to be confident and cautious as ASX shares are bouncing back
- 2 ASX healthcare shares to buy today
- 4 outstanding ASX 200 shares to buy with $4,000
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.